2020
DOI: 10.1101/2020.02.27.967760
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single cell transcriptome study

Abstract: Recent studies have demonstrated that SARS-CoV-2 cell entry depends on both ACE2 and TMPRSS2 genes (DOI: 10.1016/j.cell.2020.02.052), but our current work only focus on ACE2, which is insufficient to support the conclusion of this paper. So the authors have withdrawn their manuscript whilst they perform additional experiments and analysis to test some of their conclusions further. Therefore, the authors do not wish this work to be cited as reference for the project.

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
144
0
11

Year Published

2020
2020
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 131 publications
(161 citation statements)
references
References 29 publications
(30 reference statements)
6
144
0
11
Order By: Relevance
“…COVID-19-endothelial activation could explain the systemic impaired microcirculatory function in different vascular beds and their clinical sequelae. 6,7 Those sequelae are similar to that reported in Ebola virus patients. 4 Angiotensin-converting enzyme 2 (ACE2) is the receptor that SARS-CoV-2 uses for penetration into the cells.…”
Section: Introductionsupporting
confidence: 82%
“…COVID-19-endothelial activation could explain the systemic impaired microcirculatory function in different vascular beds and their clinical sequelae. 6,7 Those sequelae are similar to that reported in Ebola virus patients. 4 Angiotensin-converting enzyme 2 (ACE2) is the receptor that SARS-CoV-2 uses for penetration into the cells.…”
Section: Introductionsupporting
confidence: 82%
“…11 Angiotensin-converting enzyme 2 (ACE2) is known to be the receptor of SARS-CoV-2 and is highly expressed in placental tissues. 12 Animal data show that ACE2 expression changes in fetal/neonatal tissues over time and reaches a peak between the end of gestation and the rst days of postnatal life. 12 The combination of these data and our ndings con rms that transplacental transmission is indeed possible in the last weeks of pregnancy, although we cannot exclude a possible transmission and fetal consequences earlier during the pregnancy, as there are no literature data available yet.…”
Section: Discussionmentioning
confidence: 99%
“…Further studies are needed to ascertain long-term outcomes and potential intrauterine vertical transmission in pregnant women infected in the rst or second trimester. This observation is even more relevant considering that the temporal and spatial expression of the main SARS-CoV-2 receptor, ACE2, has been reported to change signi cantly in maternal-fetal interface tissues in the different trimesters 21,30 . We can speculate on the possibility that ACE2 modulation could be directly linked to placenta susceptibility to SARS-CoV-2 infection.…”
Section: Discussionmentioning
confidence: 96%
“…As recently reported, the two known SARS-CoV-2 receptors Angiotensin Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine 2 (TMPRSS2) are widely spread in speci c cell types of the maternal-fetal interface 21 . Therefore, the impact of the virus on placenta and the potential of vertical transmission of SARS-CoV-2 need to be further carefully addressed.…”
Section: Introductionmentioning
confidence: 97%